Mitochondrial encephalomyopathies: Therapeutic approaches

Neurological Sciences

Volumn 21, Issue 5 SUPPL., 2000, Pages

  DiMauro, S ^a   Hirano, M ^a   Schon, E A ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Mitochondrial encephalomyopathies; Therapy

Indexed keywords

ASCORBIC ACID; CARNITINE; CREATINE; FOLIC ACID; IDEBENONE; MENADIOL SODIUM PHOSPHATE; MENADIONE; OXYGEN RADICAL; RIBOFLAVIN; SCAVENGER; UBIDECARENONE; VALPROIC ACID;

CONFERENCE PAPER; ENCEPHALOMYOPATHY; GENE THERAPY; GENETIC COUNSELING; HUMAN; MITOCHONDRIAL RESPIRATION; PALLIATIVE THERAPY; RESPIRATORY CHAIN;

EID: 0034444472     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720070001     Document Type: Conference Paper

References (75)

1. DiMauro S, Schon EA (1998) Mitochondrial DNA and diseases of the nervous system: The spectrum. The Neuroscientist 4:53-63
2. Larsson NG, Holme B, Kristiansson B (1990) Progressive increase of the mutated mitochondrial DNA fraction in Kearns-Sayre syndrome. Pediatr Res 28:131-136
3. McShane MA, Hammans SR, Sweeney M et al (1991) Pearson syndrome and mitochondrial encephalopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39-42
4. DiMauro S, Andreu AL (2000) Mutations in mtDNA: Are we scraping the bottom of the barrel? Brain Pathol 10:431-441
5. Sue CM, Schon EA (2000) Mitochondrial respiratory chain diseases and mutations in nuclear DNA: A promising start? Brain Pathol 10:442-450
6. Hirano M, Vu TH (2000) Defects of intergenomic communication: Where do we stand? Brain Pathol 10:451-461
7. Tein I, DiMauro S, Xie Z-W, De Vivo DC (1993) Valproic acid impairs carnitine uptake in cultured human skin fibroblasts. An in vitro model for pathogenesis of valproic acid-associated carnitine deficiency. Pediat Res 34:281-287
8. Tranchant C, Mousson B, Mohr M et al (1993) Cardiac transplantation in an incomplete Kearns-Sayre syndrome with mitochondrial DNA deletion. Neuromusc Disord 3:561-566
9. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S (1996) Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 46:1329-1334
10. Sue CM, Lipsett LJ, Crimmins DS et al (1998) Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 43:350-359
11. DiMauro S (1999) Exercise intolerance and the mitochondrial respiratory chain. Ital J Neurol Sci 20:387-393
12. Dubeau F, De Stefano N, Zifkin BG, Arnold DL, Shoubridge EA (2000) Oxidative phosphorylation defect in the brains of carriers of the tRNAleu (UUR) A3243G mutation in a MELAS pedigree. Ann Neurol 47:179-185
13. De Vivo DC, DiMauro S (1999) Mitochondrial diseases. In: Swaiman KF, Ashwal S (eds) Pediatric Neurology: Principles and Practice, 3rd edn, Vol. 1. Mosby, St Louis, pp 494-509
14. Stacpoole PW (1989) The pharmacology of dichloroacetate. Metabolism 38:1124-1144
15. De Vivo DC, Jackson A, Wade C, Altmann K, Stacpoole P, DiMauro S (1990) Dichloroacetate treatment of MELAS-associated lactic acidosis. Ann Neurol 28:437
16. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL (1995) Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45:1193-1198
17. Taivassalo T, Matthews PM, De Stefano N et al (1996) Combined aerobic training and dichloroacetate improve exercise capacity and indices of aerobic metabolism in muscle cytochrome oxidase deficiency. Neurology 47:529-534
18. Kuroda Y, Ito M, Naito E et al (1997) Concomitant administration of sodium dichloroacetate and vitamin B1 for lactic acidemia in children with MELAS syndrome. J Pediatr 131:450-452
19. Saitoh S, Momoi MY, Yamagata T, Mori Y, Imai M (1998) Effects of dichloroacetate in three patients with MELAS. Neurology 50:531-534
20. Burlina AB, Milanesi O, Biban Pet al (1993) Beneficial effect of sodium dichloroacetate in muscle cytochrome c oxidase deficiency. Eur J Pediat 152:537
21. Hirano M, Silvestri G, Blake D et al (1994) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Clinical, biochemical and genetic features of an autosomal recessive mitochondrial disorder. Neurology 44:721-727
22. Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689-692
23. Kaukonen J, Juselius JK, Tiranti V et al (2000) Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289:782-785
24. Nishino I, Spinazzola A, Papadimitriou A et al (2000) Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 47:792-800
25. Tranquada RE, Bernstein S, Grant WJ (1964) Intravenous methylene blue in the therapy of lactic acidosis. Arch Intern Med 114:13-25
26. Kennaway NG, Buist NR, Darley Usmar VM et al (1984) Lactic acidosis and mitochondrial myopathy associated with deficiency of several components of complex III of the respiratory chain. Pediatr Res 18:991-999
27. Eleff S, Kennaway NG, Buist NR et al (1984) 31P-NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle. Proc Natl Acad Sci USA 81:3529-3533
28. Argov Z, Bank WJ, Maris J et al (1986) Treatment of mitochondrial myopathy due to complex III deficiency with vitamins K3 and C: A 31P-NMR follow-up study. Ann Neurol 19:598-602
29. Kennaway NG, Keightley JA, Burton MD, Quan F, Libby BD, Buist NRM (1998) Mitochondrial encephalomyopathy associated with a nonsense mutation in cytochrome b. Mol Genet Metab 63:49
30. Andreu AL, Hanna MG, Reichmann H et al (1999) Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 341:1037-1044
31. Seo BB, Kitajima-Ihara T, Chan EKL, Scheffler IE, Matsuno-Yagi A, Yagi T (1998) Molecular remedy of complex I defects: Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria restores the NADH oxidase activity of complex I-deficient mammalian cells. Proc Natl Acad Sci USA 95:9167-9171
32. Ogle RF, Christodoulou J, Fagan E et al (1997) Mitochondrial myopathy with tRNALeu(UUR) mutation and complex I deficiency responsive to riboflavin. J Pediatr 130:138-145
33. Allen RJ, DiMauro S, Coulter DL, Papadimitriou A, Rothenberg SP (1983) Kearns-Sayre syndrome with reduced plasma and cerebrospinal fluid folate. Ann Neurol 13:679-682
34. Matsuoka T, Maeda H, Goto Y, Nonaka I (1992) Muscle coenzyme Q10 in mitochondrial encephalomyopathies. Neuromusc Disord 1:443-447
35. Zierz S, Jahns G, Jerusalem F (1989) Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J Neurol 236:97-101
36. Stanley CA, De Leeuw S, Coates PM et al (1991) Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 30:709-716
37. Tein I, DeVivo DC, Bierman F et al (1990) Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediat Res 28:247-255
38. Pons R, Carrozzo R, Tein I et al (1997) Deficient muscle carnitine transport in primary carnitine deficiency. Pediat Res 42:583-587
39. Shoji Y, Koizumi A, Kayo T et al (1998) Evidence for linkage of human primary systemic carnitine deficiency with D5S436: A novel gene locus on chromosome 5q. Am J Hum Genet 63:101-108
40. Lamhonwah A-M, Tein I (1988) Carnitine uptake defect: Frameshift mutations in the human plasmalemmal carnitine transporter gene. Biochem Biophys Res Commun 252:396-401
41. Ogasahara S, Engel AG, Frens D, Mack D (1989) Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 86:2379-2382
42. 10 deficiency. Neurology 46:A420
43. 10 deficiency. Neurology 48:1238-1243
44. 10 deficiency. Lancet 356:391-395
45. 10 deficiency. Neurology (in press)
46. Tarnopolsky MA, Roy BD, MacDonald JR (1997) A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 20:1502-1509
47. Manfredi G, Beal MF (2000) The role of mitochondria in the pathogenesis of neurodegenerative diseases. Brain Pathol 10:462-472
48. Delanty N, Dichter MA (2000) Antioxidant therapy in neurologic disease. Arch Neurol 57:1265-1270
49. 10. Neurology 36:45-53
50. 10 administration. J Neurol Neurosurg Psychiatry 50:1475-1481
51. 10. Neurology 38:892-899
52. 10 and idebenone. J Neurol Sci 90:263-271
53. Ikejiri Y, Mori E, Ishii K, Nishimoto K, Yasuda M, Sasaki M (1996) Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS. Neurology 47:583-585
54. 10 therapy. J Neurol 245:681-685
55. Bendahan D, Desnuelle C, Vanuxem D et al (1992) 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42:1203-1208
56. 10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): Evaluation by noninvasive tissue oximetry. J Neurol Sci 162:65-68
57. 10 in parkinsonian patients. Neurology 50:793-795
58. Rustin P, von Kleist-Retzow J-C, Chantrel-Groussard K, Sidi D, Munnich A, Rotig A (1999) Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study. Lancet 354:477-479
59. Wispe JR, Warner BB, Clark JC et al (1992) Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 267:23937-23941
60. Haydar NA, Conn HL, Afifi A, Wakid N, Ballas S, Fawaz K (1971) Severe hypermetabolism with primary abnormality of skeletal muscle mitochondria. Ann Intern Med 74:548-558
61. DiMauro S, Bonilla E, Lee CP et al (1976) Luft's disease. Further biochemical and ultrastructural studies of skeletal muscle in the second case. J Neurol Sci 27:217-232
62. Murphy MP, Smith RAJ (2000) Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 41:235-250
63. Nagley P, Farrell LB, Gearing DP, Nero D, Meltzer G, Devenish RJ (1988) Assembly of functional proton-tramslocating ATPase complex in yeast mitochondria with cytoplasmically synthesised subunit 8, a polypeptide normally encoded by the organelle. Proc Natl Acad Sci USA 85:2091-2095
64. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN (1997) Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 15:212-215
65. Chinnery PF, Taylor RW, Diekert K, Lill R, Turnbull DM, Lightowlers RN (1999) Peptide nucleic acid delivery to human mitochondria. Gene Therapy 6:1919-1928
66. Manfredi G, Gupta N, Vazquez-Memije ME et al (1999) Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J Biol Chem 274:9386-9391
67. Clark KM, Bindoff LA, Lightowlers RN et al (1997) Reversal of a mitochondrial DNA defect in human skeletal muscle. Nat Genet 16:222-224
68. Fu K, Hartlen R, Johns T, Genge A, Karpati G, Shoubridge EA (1996) A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet 5:1835-1840
69. Shoubridge EA, Johns T, Karpati G (1997) Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibers in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Mol Genet 6:2239-2242
70. Taivassalo T, Fu K, Johns T, Arnold D, Karpati G, Shoubridge EA (1999) Gene shifting: a novel therapy for mitochondrial myopathy. Hum Mol Genet 8:1047-1052
71. Andrews RM, Griffiths PG, Chinnery PF, Turnbull DM (1999) Evaluation of bupivacaine-induced muscle regeneration in the treatment of ptosis in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Eye 13:769-772
72. Karadimas CL, Greenstein P, Sue CM et al (2000) Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mtDNA. Neurology 55:644-649
73. Rubenstein DS, Thomasma DC, Schon EA, Zinaman MJ (1995) Germ-line therapy to cure mitochondrial disease: Protocol and ethics of in vitro ovum nuclear transplantation. Cambridge Quart Healthcare Eth 4:316-339
74. White SL, Shanske S, McGill JJ et al (1999) Mitochondrial DNA mutations at nucleotide 8993 show a lack of tissue-or age-related variation. J Inherit Metab Dis 22:899-914
75. White SL, Shanske S, Biros I, Warwick L et al (1999) Two cases of prenatal analysis for the pathogenic substitution at nucleotide 8993 in mitochondrial DNA. Prenatal Diagn 19:1165-1168